Najlepsi Guz nadnercza do leczenia guza nadnercza w Izraelu – TOP 7 lekarzy

Prof. Merimsky kieruje Oddziałem Onkologii Tkanek Miękkich i Kości w Centrum Medycznym Sourasky, specjalizując się w rzadkich i złożonych nowotworach.

• Posiada ponad 30-letnie doświadczenie w onkologii, koncentrując się na leczeniu mięsaków.
• Odbył staż specjalistyczny w zakresie leczenia mięsaków w Institut Gustave Roussy w Paryżu.
• Jest członkiem wydziału ESMO ds. mięsaków tkanek miękkich i kości.
• Prowadzi szeroko zakrojone badania w dziedzinie immunologii nowotworów i terapii celowanych.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr Levin koordynuje krajowy program leczenia mięsaków u dzieci, zajmując się terapią nowotworów kości i tkanek miękkich. Kształcił się w wiodącym światowym ośrodku onkologii ortopedycznej we Włoszech.

• Starszy pediatra ze specjalizacją w hematologii i onkologii dziecięcej
• Dyrektor oddziału hematologii i onkologii dziecięcej w Centrum Medycznym Sourasky
• Koncentruje się na leczeniu chorób krwi i nowotworów u dzieci
• Członek Izraelskiego Towarzystwa Hematologii i Onkologii Dziecięcej (ISPHO)
• Kieruje oddziałem zaburzeń krzepnięcia i zakrzepicy

Dyrektor ds. hospitalizacji onkologicznej w Centrum Medycznym Tel Awiw (Ichilov), dr Stepfansky prowadzi badania kliniczne w onkologii w fazach 1–3.

• Specjalizuje się w chorobach wewnętrznych i onkologii
• Posiada ponad 20-letnie doświadczenie kliniczne w onkologii
• Jest głównym i pomocniczym badaczem w onkologicznych badaniach klinicznych
• Praktykował na Uniwersytecie w Grodnie oraz w Centrum Medycznym w Mozyrzu

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.